Buy One Get One free -Llimited Time Offer X
Arpimune ME is a commercial drug that is prescribed in the form of Capsule, Solution. Psoriasis, Liver transplant are some of its major therapeutic uses. The alternative uses of Arpimune ME have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Arpimune ME. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Arpimune ME also has some side effects, the most common being Increased hair growth, Loss of appetite. While these are the most often observed Arpimune ME side effects, there are can be others also. These have been listed below. Such side effects of Arpimune ME normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Arpimune ME's effect during pregnancy is Severe and Severe while nursing. Warnings related to Arpimune ME's effects on the liver, heart and kidney, if any, have been listed below.
Arpimune ME is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. Other conditions have been mentioned below in the Arpimune ME contraindications section.
Besides this, Arpimune ME may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arpimune ME is considered safe while driving, and is addictive.
Arpimune ME is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Arpimune ME is used -
Severe
Moderate
Mild
Common
Is the use of Arpimune ME safe for pregnant women?
Pregnant women may get severe side effects after taking Arpimune ME. If you are pregnant, do not take Arpimune ME without a doctor's advice.
Is the use of Arpimune ME safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Arpimune ME. So it is adviced to consult the doctor before using it.
What is the effect of Arpimune ME on the Kidneys?
Arpimune ME rarely harms the kidneys.
What is the effect of Arpimune ME on the Liver?
Arpimune ME may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Arpimune ME on the Heart?
Arpimune ME can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Arpimune ME should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Arpimune ME unless your doctor advises you to do so -
Is this Arpimune ME habit forming or addictive?
No, there is no any evidence that Arpimune ME is addictive.
Interaction between Food and Arpimune ME
Information is not available on the interaction of any foods with Arpimune ME, due to a lack of research on this.
Interaction between Alcohol and Arpimune ME
No research has been done on this till date. Therefore, it is not known what the effect of taking Arpimune ME with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 879-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380